141 – 150 of 228
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review
-
Mark
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
(
- Contribution to journal › Article
-
Mark
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
(
- Contribution to journal › Article
-
Mark
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
(
- Contribution to journal › Article
-
Mark
IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
(
- Contribution to journal › Article
-
Mark
Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.
(
- Contribution to journal › Article
-
Mark
Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalis.
(
- Contribution to journal › Article
-
Mark
A new approach to assess COPD by identifying lung function break-points.
(
- Contribution to journal › Article
-
Mark
The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used
(
- Contribution to journal › Article
-
Mark
Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.
(
- Contribution to journal › Article